Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Monoclonal Antibody

Anti-Rocuronium Bromide Monoclonal Antibody (1A203)

Catalog #:   MGK81203 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: ELISA
Accession: CAS: 119302-91-9
Overview

Catalog No.

MGK81203

Species reactivity

General

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Immunogen

Rocuronium Bromide conjugated with Carrier protein.

Tested applications

ELISA: 1:2000-1:4000

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

CAS: 119302-91-9

Applications

ELISA

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

1A203

Data Image
References

Antibody-secreting cell repertoires hold high-affinity anti-rocuronium specificities that can induce anaphylaxis in vivo., PMID:39892658

Exploring the Landscape of Perioperative Immediate Hypersensitivity: A Comprehensive 6-Year Monocentric Observational Analysis on Epidemiology and Risk Factors., PMID:39571554

An Experimental Study to Optimize Neuromuscular Blockade Protocols in Cynomolgus Macaques: Monitoring, Doses, and Antagonism., PMID:39307982

Rocuronium-specific antibodies drive perioperative anaphylaxis but can also function as reversal agents in preclinical models., PMID:39259810

IgE-Mediated Mast Cell Responses to Rocuronium: A Matter of Protonation Status., PMID:38960735

Perioperative Management of Paraneoplastic Necrotizing Myopathy in Thyroidectomy: A Case Report., PMID:38694410

Epidemiology of perioperative anaphylaxis in France in 2017-2018: the 11th GERAP survey., PMID:38493055

Are changes in antibiotic prophylaxis recommendations responsible for an increased risk of cefazolin allergy?, PMID:38278354

Neuromuscular blocking agent re-exposure in a retrospective cohort with neuromuscular blocking agent-associated anaphylaxis., PMID:37356714

Comparison of the passive mast cell activation test with the basophil activation test for diagnosis of perioperative rocuronium hypersensitivity., PMID:37031026

Rocuronium bromide suppresses esophageal cancer via blocking the secretion of C-X-C motif chemokine ligand 12 from cancer associated fibroblasts., PMID:37029408

Causes and Diagnostic Usefulness of Tryptase Measurements for Anaphylaxis in a Korean Tertiary Care General Hospital., PMID:36444545

General anesthesia, using remimazolam, for the patient with myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD): A case report., PMID:36401433

Inhibition of MRGPRX2 but not FcεRI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist., PMID:36275683

Anesthetic management of a patient with subclinical myasthenia gravis who underwent a thymectomy: a case report., PMID:35835969

Reliability of Early and Late Testing for Suspected Perioperative Hypersensitivity., PMID:34767998

MRGPRX2 and Adverse Drug Reactions., PMID:34421893

Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones., PMID:34385999

Rocuronium reversed with sugammadex for thymectomy in myasthenia gravis: A retrospective analysis of complications from Japan., PMID:34226417

Does Sugammadex Suppress Allergic Inflammation Due to Rocuronium in Animal Model of Rat?, PMID:33938193

Immunoglobulin E cross-linking or MRGPRX2 activation: clinical insights from rocuronium hypersensitivity., PMID:33153719

Reply to "Does sugammadex have multiple mechanisms for causing anaphylaxis?"., PMID:32620443

Does sugammadex have multiple mechanisms for causing anaphylaxis?, PMID:32620442

Application of specific-to-total IgE ratio does not benefit diagnostic performance of serologic testing for rocuronium allergy., PMID:32620258

A novel MRGPRX2-targeting antagonistic DNA aptamer inhibits histamine release and prevents mast cell-mediated anaphylaxis., PMID:32320700

Anesthetic care for patients with anti-NMDA receptor encephalitis., PMID:32317869

Anaphylaxis to sugammadex-rocuronium inclusion complex: An IgE-mediated reaction due to allergenic changes at the sugammadex primary rim., PMID:31785411

Efficacy of Sugammadex in Preventing Skin Test Reaction in a Patient With Confirmed Rocuronium Anaphylaxis: A Case Report., PMID:30720535

Rocuronium Hypersensitivity: Does Off-Target Occupation of the MRGPRX2 Receptor Play a Role?, PMID:30315997

Neuromuscular blocking agents induced anaphylaxis: Results and trends of a French pharmacovigilance survey from 2000 to 2012., PMID:29654608

Concurrent immunoglobulin E-mediated neuromuscular blocking agent allergy in systemic mastocytosis., PMID:29481892

Teicoplanin anaphylaxis associated with surgical prophylaxis., PMID:29319891

Current Knowledge and Management of Hypersensitivity to Perioperative Drugs and Radiocontrast Media., PMID:28483312

In Vitro Diagnosis of Immediate Drug Hypersensitivity Anno 2017: Potentials and Limitations., PMID:28258478

Anaesthetic hypersensitivity reactions in France between 2011 and 2012: the 10th GERAP epidemiologic survey., PMID:28164269

[Prevention of Postoperative Delirium and Agitation in a Patient with Anti-NMDA Receptor Encephalitis: A Case Report]., PMID:30380285

Six years without pholcodine; Norwegians are significantly less IgE-sensitized and clinically more tolerant to neuromuscular blocking agents., PMID:27859358

Quantification of specific IgE antibodies in immediate drug hypersensitivity: More shortcomings than potentials?, PMID:27376983

Postoperative Respiratory Failure in a Patient with Undiagnosed Myastenia Gravis., PMID:27366570

Weight-based dosing in medication use: what should we know?, PMID:27110105

[Anesthetic Management for a Patient with Stiff-person Syndrome]., PMID:27017773

Response to rocuronium and its determinants in patients with myasthenia gravis: A case-control study., PMID:26086278

Predictive value of allergy tests for neuromuscular blocking agents: tackling an unmet need., PMID:24848972

Sugammadex and anaphylaxis in the operating theater., PMID:24666509

[Case of delayed extubation in a woman with low pulmonary function]., PMID:24601107

Rocuronium anaphylaxis in a 3-year-old girl with no previous exposure to neuromuscular blocking agents., PMID:23859417

[A case of prolonged neuromuscular blockade possibly related to a high anti-acetylcholine receptor antibody level]., PMID:23697199

Utility of opium seed extract tests in preventing hypersensitivity reactions during surgery., PMID:23332099

Anesthetic management of a parturient with neuromyelitis optica., PMID:22922089

[Sugammadex: the last shot for anaphylactic shock due to rocuronium?]., PMID:22575774

Datasheet
$ 196
Product specifications
50 μg 196 100 μg 313

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Rocuronium Bromide Monoclonal Antibody (1A203) [MGK81203]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only